Recap: Ironwood Pharmaceuticals Q1 Earnings - Ironwood Pharmaceuticals (NASDAQ:IRWD)

Ironwood Pharmaceuticals IRWD reported its Q1 earnings results on Thursday, May 4, 2023 at 07:00 AM.

Here's what investors need to know about the announcement.

Ironwood Pharmaceuticals beat estimated earnings by 4.17%, reporting an EPS of $0.25 versus an estimate of $0.24.

Revenue was up $6.53 million from the same period last year.

Last quarter the company missed on EPS by $0.0 which was followed by a 4.41% increase in the share price the next day.

Here's a look at Ironwood Pharmaceuticals's past performance:

Quarter	Q4 2022	Q3 2022	Q2 2022	Q1 2022
EPS Estimate	0.27	0.26	0.30	0.25
EPS Actual	0.27	0.28	0.21	0.21
Revenue Estimate	110.84M	109.11M	103.51M	94.35M
Revenue Actual	107.20M	108.64M	97.23M	97.53M

To track all earnings releases for Ironwood Pharmaceuticals visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.